A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

Recruiting

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(24 sites)

United States

The Luskin Orthopaedic Institute for Children- Site Number : 8400013, Los Angeles, California

The Center for Inherited Blood Disorders- Site Number : 8400009, Orange, California

Cure 4 The Kids Foundation- Site Number : 8400001, Las Vegas, Nevada

Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400008, Hackensack, New Jersey

Belgium

Investigational Site Number : 0560002, Brussels